Mistras Group
MG
20.64
-0.24
-1.15%
Mistras Group
US · MG
#3552 by market cap
20.64
-0.24
-1.15%
Live - 5344 symbols - heartbeat 194s ago
· 2026-10-08 09:53
Pre-market
21.18
+1.44%
After-hours
20.88
0.00%
- Market cap
- 657.60M
- P/E (TTM)i
- 24.87
- P/Bi
- 2.74
- EPSi
- 0.53
- Div yieldi
- 0.00%
- 52W posi
- 91%
Reader sentiment
Are you bullish or bearish on MG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.91, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.77% YoY
Margins
- Gross margin
- 28.25%
- Operating margin
- 7.35%
- Net margin
- 2.33%
Key ratios & quality
- Enterprise valuei
- 825.49M
- PEG ratioi
- 0.67
- Altman Z-Scorei
- 2.91
PEG uses trailing P/E against the 3-year net income growth rate (37.34%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 742.35M | 748.59M | 592.57M | 677.13M | 687.37M | 705.47M | 729.64M | 724.02M |
| Gross profit | 207.87M | 217.30M | 178.53M | 197.15M | 198.17M | 184.30M | 192.17M | 204.51M |
| Selling & admin expenses | 171.59M | 169.47M | 157.16M | 161.33M | 166.40M | 147.24M | 135.45M | 139.88M |
| Research & development | 3.31M | 3.05M | 2.89M | 2.52M | 1.99M | 1.72M | 1.12M | 1.03M |
| Operating profit | 20.37M | 25.01M | 4.96M | 21.35M | 19.08M | 25.23M | 44.54M | 53.23M |
| Pretax profit | 14.27M | 10.44M | -114.17M | 7.29M | 9.29M | -18.67M | 24.24M | 22.48M |
| Tax | 7.43M | 4.36M | -14.71M | 3.40M | 2.72M | -1.22M | 5.27M | 5.56M |
| Net profit | 6.85M | 6.08M | -99.47M | 3.89M | 6.57M | -17.45M | 18.97M | 16.92M |
| Basic EPS | 0 | 0 | -3 | 0 | 0 | -1 | 1 | 1 |
| Diluted EPS | 0.23 | 0.21 | -3.41 | 0.13 | 0.21 | -0.58 | 0.60 | 0.53 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 161.62M | 185.41M | 195.55M | 181.46M | 169.03M | 193.13M |
| Gross profit | 40.89M | 53.95M | 58.19M | 51.48M | 44.73M | 56.45M |
| Selling & admin expenses | 35.65M | 39.79M | 33.48M | 30.95M | 36.99M | 38.72M |
| Research & development | 299.00K | 269.00K | 210.00K | 250.00K | 221.00K | 243.00K |
| Operating profit | 2.08M | 11.38M | 22.15M | 17.63M | 5.16M | 14.47M |
| Pretax profit | -4.34M | 4.19M | 17.00M | 5.63M | 2.74M | 9.82M |
| Tax | -1.17M | 1.06M | 3.80M | 1.87M | 378.00K | 2.27M |
| Net profit | -3.17M | 3.13M | 13.20M | 3.76M | 2.36M | 7.55M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.10 | 0.10 | 0.41 | 0.12 | 0.07 | 0.23 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 202.79M | 179.16M | 162.59M | 161.34M | 167.88M | 180.36M | 172.47M | 216.19M |
| Cash & ST investments | 25.54M | 15.02M | 25.76M | 24.11M | 20.49M | 17.65M | 18.32M | 28.01M |
| Inventory | 13.05M | 13.41M | 13.13M | 12.69M | 13.56M | 15.28M | 14.49M | 14.00M |
| Total assets | 694.04M | 719.88M | 583.31M | 562.20M | 534.90M | 534.78M | 523.04M | 578.78M |
| Total current liabilities | 100.47M | 109.24M | 109.85M | 121.42M | 103.73M | 116.52M | 114.93M | 124.31M |
| Short-term debt | 10.76M | 20.86M | 24.79M | 33.97M | 22.00M | 24.75M | 28.28M | 30.76M |
| Long-term debt | 283.79M | 248.12M | 209.54M | 182.40M | 183.83M | 181.50M | 158.06M | 165.14M |
| Total liabilities | 422,963,000.00 | 433,856,000.00 | 386,094,000.00 | 361,283,000.00 | 336,155,000.00 | 344,273,000.00 | 324,143,000.00 | 343,136,000.00 |
| Total equity | 271.07M | 286.02M | 197.22M | 200.91M | 198.75M | 190.50M | 198.90M | 235.65M |
| Retained earnings | 71.55M | 77.61M | -21.85M | -17.99M | -11.49M | -28.94M | -9.98M | 6.85M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 175.97M | 213.31M | 237.50M | 216.19M | 210.89M | 218.50M |
| Cash & ST investments | 18.54M | 19.96M | 27.81M | 28.01M | 24.99M | 21.99M |
| Inventory | 14.14M | 15.12M | 14.80M | 14.00M | 15.28M | 16.73M |
| Total assets | 526.79M | 571.04M | 596.26M | 578.78M | 572.67M | 584.12M |
| Total current liabilities | 117.55M | 128.49M | 125.79M | 124.31M | 116.82M | 127.52M |
| Short-term debt | 29.49M | 29.98M | 30.50M | 30.76M | 30.69M | 31.23M |
| Long-term debt | 159.50M | 176.35M | 189.24M | 165.14M | 168.49M | 159.26M |
| Total liabilities | 327,788,000.00 | 354,868,000.00 | 368,430,000.00 | 343,136,000.00 | 339,073,000.00 | 343,946,000.00 |
| Total equity | 199.00M | 216.18M | 227.83M | 235.65M | 233.60M | 240.18M |
| Retained earnings | -13.17M | -10.15M | 2.96M | 6.85M | 9.24M | 16.82M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 41.66M | 59.11M | 67.80M | 42.26M | 26.41M | 26.75M | 50.13M | 32.98M |
| Depreciation & amortization | 34.41M | 38.53M | 35.71M | 34.92M | 33.29M | 34.10M | 33.01M | 31.01M |
| Free cash flow | 20.54M | 36.19M | 52.03M | 22.99M | 12.99M | 3.10M | 27.14M | 3.79M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 25.54M | 15.02M | 25.76M | 24.11M | 20.49M | 17.65M | 18.32M | 28.01M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 5.65M | -9.26M | 4.46M | 32.14M | 2.81M | 14.91M |
| Depreciation & amortization | 7.76M | 7.71M | 7.69M | 7.85M | 7.98M | 8.27M |
| Free cash flow | -177.00K | -15.74M | -4.94M | 24.65M | -4.45M | 8.19M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 18.54M | 19.96M | 27.81M | 28.01M | 24.99M | 21.99M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 2.52 | 2.18 | -41.20 | 1.94 | 3.26 | -8.98 | 9.75 | 7.76 |
| ROA %i | 1.10 | 0.86 | -15.26 | 0.67 | 1.18 | -3.26 | 3.58 | 3.06 |
| ROIC %i | 2.46 | 2.81 | -17.46 | 2.72 | 3.31 | -0.43 | 8.00 | 6.57 |
| 5-year avg ROE %i | -- | -- | -- | -7.07 | -6.26 | -8.56 | -7.05 | 2.75 |
| EBIT margin %i | 2.99 | 3.22 | -17.08 | 2.68 | 2.88 | -0.27 | 5.66 | 5.13 |
| FCF / sales %i | 2.77 | 4.83 | 8.78 | 3.39 | 1.89 | 0.44 | 3.72 | 0.52 |
| Current ratioi | 2.02 | 1.64 | 1.48 | 1.33 | 1.62 | 1.55 | 1.50 | 1.74 |
| Quick ratioi | 1.73 | 1.38 | 1.21 | 1.10 | 1.39 | 1.29 | 1.27 | 1.47 |
| Debt / assetsi | 43.75 | 39.18 | 42.08 | 40.22 | 40.36 | 40.67 | 38.53 | 36.84 |
| LT debt / equityi | 108.11 | 91.37 | 111.99 | 95.75 | 97.69 | 101.35 | 87.23 | 77.62 |
| Interest coveragei | 2.80 | 1.76 | -7.81 | 1.67 | 1.88 | -0.11 | 2.42 | 2.54 |
| Revenue CAGR (3Y) %i | 1.20 | 1.12 | -5.45 | -3.02 | -2.80 | 5.99 | 2.52 | 1.75 |
| Net income CAGR (3Y) %i | -21.21 | -32.38 | -- | -17.35 | 2.36 | -- | 69.98 | 37.34 |
| FCF CAGR (3Y) %i | -13.01 | -9.59 | 13.88 | 3.82 | -28.93 | -60.95 | 5.70 | -33.68 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 7.66 | 5.59 | 8.38 | 7.76 | 10.38 | 11.84 |
| ROA %i | 2.76 | 2.04 | 3.16 | 3.06 | 4.08 | 4.67 |
| ROIC %i | 6.70 | 5.42 | 6.74 | 6.57 | 7.78 | 8.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.92 | 4.44 | 5.35 | 5.13 | 5.98 | 6.67 |
| FCF / sales %i | 4.57 | 2.58 | -- | 0.52 | -- | 3.17 |
| Current ratioi | 1.50 | 1.66 | 1.89 | 1.74 | 1.81 | 1.71 |
| Quick ratioi | 1.25 | 1.40 | 1.61 | 1.47 | 1.51 | 1.44 |
| Debt / assetsi | 38.89 | 38.92 | 39.31 | 36.84 | 37.84 | 36.06 |
| LT debt / equityi | 88.27 | 89.06 | 89.65 | 77.62 | 79.76 | 74.75 |
| Interest coveragei | 2.18 | 1.98 | 2.57 | 2.54 | 3.08 | 3.50 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- North America is the largest reported line at 81.10% of revenue, across 4 reported segments.
- The next-largest line, International, is a distant second at 19.68% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
North America81.10%
International19.68%
Products and Systems2.03%
Quote time 2026-10-08 09:53:12 · For reference only, not investment advice and not tailored to your situation.